If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Omega Healthcare Investors Inc. (NYSE:OHI) is a real estate investment trust that primarily invests in skilled nursing and assisted living facilities in the U.S. and the U.K.

It is set to report its Q2 2025 earnings on July 31. Wall Street analysts expect the company to post EPS of $0.75, up from $0.71 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $295.80 million, up from $252.75 million a year earlier.

Don’t Miss:

The company’s stock traded at approximately $34.79 per share 10 years ago. If you had invested $10,000, you could have bought roughly 287 shares. Currently, shares trade at $36.67, meaning your investment’s value could have grown to $10,540 from stock price appreciation alone. However, Omega Healthcare also paid dividends during these 10 years.

Omega Healthcare’s dividend yield is currently 7.31%. Over the last 10 years, it has paid about $27.11 in dividends per share, which means you could have made $7,792 from dividends alone.

Summing up $10,540 and $7,792, we end up with the final value of your investment, which is $18,332. This is how much you could have made if you had invested $10,000 in Omega Healthcare stock 10 years ago. This means a total return of 83.32%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 256.40%.

Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara’s Air-to-Water Pod Cuts Plastic and Costs — And You Can Invest At Just $6.37/Share 

Omega Healthcare has a consensus rating of “Buy” and a price target of $36.28 based on the ratings of 20 analysts. The price target implies around 1% potential downside from the current stock price.

The company on May 1 announced its Q1 2025 earnings, posting FFO of $0.75, beating the consensus estimate of $0.74, while revenues of $276.80 million came in below the consensus of $288.69 million, as reported by Benzinga.

“We are pleased with our first quarter results, as we continue to grow FAD per share, while further de-levering the balance sheet. We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share,” said CEO Taylor Pickett.